View more on these topics

Skandia to re-enter critical illness market

Skandia is re-entering the critical-illness market more than two and a half years after it pulled out of the sector.

The provider is expected to announce details of its new offering within the next few weeks.

Money Marketing revealed the provider was considering re-entering the CI sector in February 2012.

In July 2010, Skandia announced it was pulling its critical-illness product in September of that year as part of a strategy to move away from its older style policies to prepare for the RDR.

Skandia head of protection Ian Jefferies says: “We are looking to launch an exciting new critical illness product in the near future, which we believe will be of real interest to advisers.”

London & Country sales director Michael Aldridge says: “It is always good to have more competition and if Skandia can carve out a niche and offer something a bit different, the customer will benefit.”



Hargreaves Lansdown says RDR helped it achieve record inflows

Hargreaves Lansdown has cited a rise in self-investing post-RDR after attracting a record £1.8bn of net inflows in the first quarter of the year. The inflows bring the group’s assets under administration to a record £35.1bn, a 23 per cent increase from the start of 2013. The group reported  £4.7bn of new assets in the […]


Structured products body hits back at Wheatley’s “spread bets on steroids” claim

<!– <!– <!– <!– <!– –> –> –> –> –> <!– <!– <!– –> –> –> The UK Structured Products Association has hit back at “sensationalist” comments made by Financial Conduct Authority chief executive Martin Wheatley which compared many structured products to “spread bets on steroids”. Speaking at the London School of Economics last week, […]


Axa closes UK bancassurance arm; 450 jobs at risk

Axa is set to close its bancassurance division following a strategic review of the business, Money Marketing can reveal. Axa currently has two UK banking partners – the Co-operative Banking Group and Clydesdale and Yorkshire Banks. The decision to close the bancassurance arm will result in the loss of approximately 450 Axa UK roles and […]

Tapering of annual allowance – adjusted and threshold income

The definitions of adjusted income and threshold income used to determine whether, and to what extent, someone’s annual allowance will be reduced can be confusing.  Here we try to make sense of it all. The annual allowance will be reduced for high income individuals from 6 April 2016.  Our previous article Tapering of annual allowance […]


News and expert analysis straight to your inbox

Sign up


There are 4 comments at the moment, we would love to hear your opinion too.

  1. Why an “exciting” new product, how about a boring but well designed product? and why is going to be of interst to advisers? have they found ways of paying large commissions on it?

    what part of putting CONSUMERS first are Skandia having a problem understanding?

  2. @ Anonymous. Some people’s glasses are half empty and some are half-full.

    In your case it seems as if some bugger and slurped the whole lot!

    Surely you would welcome further competition and a new entrant?

  3. This is interesting and welcome.

    We don’t need another Critical Illness plan. To move the market forward we need something that is truely severity based. We only have the choice of one in this area.

  4. @ John Franklin.


Leave a comment


Why register with Money Marketing ?

Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

News & analysis delivered directly to your inbox
Register today to receive our range of news alerts including daily and weekly briefings

Money Marketing Events
Be the first to hear about our industry leading conferences, awards, roundtables and more.

Research and insight
Take part in and see the results of Money Marketing's flagship investigations into industry trends.

Have your say
Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

Register now

Having problems?

Contact us on +44 (0)20 7292 3712

Lines are open Monday to Friday 9:00am -5.00pm